ADD CONDITION

items per page

Aspercreme with Lidocaine Foot Pain Creme

Last content change checked dailysee data sync status

Active ingredient
Lidocaine Hydrochloride 4 g/100 g
Other brand names
Drug classes
Amide Local Anesthetic, Antiarrhythmic
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2018
Label revision date
December 19, 2025
Active ingredient
Lidocaine Hydrochloride 4 g/100 g
Other brand names
Drug classes
Amide Local Anesthetic, Antiarrhythmic
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2018
Label revision date
December 19, 2025
Manufacturer
Chattem, Inc.
Registration number
M017
NDC root
41167-0586

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Aspercreme is a pain relief cream that contains 4% lidocaine, a medication that helps numb the area where it is applied. This cream is designed to provide temporary relief from pain, making it a useful option for those dealing with discomfort in specific areas of the body.

When you apply Aspercreme, it works by blocking pain signals in the skin, allowing you to experience some relief from your symptoms. It's important to use it as directed to ensure you get the best results.

Uses

You can use this medication for the temporary relief of pain. It is designed to help alleviate discomfort, making it easier for you to go about your daily activities.

Rest assured, there are no known teratogenic effects (which means it does not cause birth defects) associated with this medication, so it is considered safe in that regard.

Dosage and Administration

When using this medication, you should apply a thin layer to the affected area of your skin every 6 to 8 hours. Make sure not to exceed 3 to 4 applications in a single day. After applying, gently massage the medication into your skin until it is fully absorbed. It’s important to wash your hands thoroughly with soap and water after each use to avoid spreading the medication to other areas.

If you are considering this treatment for a child under 12 years of age, it’s best to consult with a doctor first to ensure it’s safe and appropriate for them.

What to Avoid

It's important to use this product safely to avoid potential issues. You should never use it in large quantities or apply it to wounds, irritated, or damaged skin. Additionally, avoid using it with a heating pad, as this can increase the risk of side effects.

While using this product, make sure not to bandage the area tightly, and keep it away from your eyes and mucous membranes (the moist tissues lining certain body parts). Also, refrain from exposing the treated area to local heat or direct sunlight, as this can lead to complications. Following these guidelines will help ensure your safety and the effectiveness of the product.

Side Effects

When using this product, it's important to follow the directions carefully. You should avoid using it in large amounts, on wounds or damaged skin, or with a heating pad. Be cautious to keep it away from your eyes and mucous membranes, and do not expose the treated area to heat or direct sunlight.

If your condition worsens, symptoms last more than 7 days, or if you notice redness or excessive irritation, stop using the product and consult a doctor. Additionally, if you experience severe burning pain, swelling, or blistering at the application site, seek medical advice. If the product is swallowed, contact a Poison Control Center or seek medical help immediately.

Warnings and Precautions

This product is for external use only, so please avoid using it on wounds or any irritated or damaged skin. It's important to follow the directions carefully and not to use it in large quantities or with a heating pad. When applying, do not bandage tightly, and keep it away from your eyes and mucous membranes. Additionally, avoid exposing the treated area to local heat or direct sunlight.

If your condition worsens or symptoms last longer than 7 days, or if they clear up and then return within a few days, stop using the product and consult your doctor. You should also seek medical advice if you notice redness, excessive skin irritation, or experience severe burning pain, swelling, or blistering at the application site. Remember to keep this product out of reach of children, and if swallowed, seek medical help or contact a Poison Control Center immediately.

Overdose

If you or someone else has swallowed a medication and you suspect an overdose, it’s important to act quickly. Contact a medical professional or call a Poison Control Center immediately for guidance.

Signs of an overdose can vary, but they may include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these symptoms, seek emergency medical help right away. Remember, it’s always better to be safe and get professional advice in these situations.

Pregnancy Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using this medication. They can provide guidance on whether it’s safe for you and your baby. Always prioritize your health and the health of your child by seeking expert advice.

Lactation Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using any medication. This ensures that you understand any potential risks and can make informed decisions about your health and the health of your baby. Always prioritize open communication with your doctor regarding your breastfeeding journey.

Pediatric Use

If your child is under 12 years old, it's important to consult a doctor before using this medication. For children aged 12 and older, you can apply a thin layer to the affected area every 6 to 8 hours, but be sure not to exceed 3 to 4 applications in a single day. Always follow these guidelines to ensure safe and effective use for your child.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult considering this medication, it’s important to consult with a healthcare provider. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your treatment may need to change based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that your treatment is safe and effective, especially if you have any concerns about your kidney health.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication should be used if you have hepatic impairment (issues with liver function).

Always consult your healthcare provider for personalized advice and to ensure that any medication you take is safe and appropriate for your liver health. They can help determine the best course of action based on your individual situation.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you. Always share your complete list of medications and any recent lab tests to avoid any potential issues. Your health and safety should always come first.

Storage and Handling

To ensure the safety and effectiveness of your product, store it at room temperature. After each use, make sure to close the cap tightly to prevent contamination or leakage. It's important to keep the product out of reach of children, and it comes in child-resistant packaging to help protect them from accidental access.

By following these simple storage and handling guidelines, you can help maintain the product's integrity and ensure safe usage.

Additional Information

You should apply a thin layer of the medication to the affected area every 6 to 8 hours, but no more than 3 to 4 times a day. If you are pregnant or breastfeeding, it's important to consult a healthcare professional before using this product. Additionally, keep the medication out of reach of children. If it is swallowed, seek medical help or contact a Poison Control Center immediately.

FAQ

What is Aspercreme?

Aspercreme is a pain relief cream that contains 4% lidocaine, providing temporary relief of pain.

How should I use Aspercreme?

Apply a thin layer to the affected area every 6 to 8 hours, not exceeding 3 to 4 times daily. Massage until thoroughly absorbed into the skin.

Are there any precautions I should take when using Aspercreme?

Yes, avoid using it in large quantities, on wounds or irritated skin, and do not use with a heating pad. Also, avoid contact with eyes and mucous membranes.

What should I do if my symptoms persist?

Stop use and ask a doctor if your condition worsens, symptoms persist for more than 7 days, or if you experience severe burning pain, swelling, or blistering.

Is Aspercreme safe for children?

Children under 12 years of age should ask a doctor before use. For adults and children 12 years and older, it can be used as directed.

Can I use Aspercreme if I am pregnant or breastfeeding?

If you are pregnant or breastfeeding, consult a health professional before using Aspercreme.

What should I do if I accidentally swallow Aspercreme?

If swallowed, seek medical help or contact a Poison Control Center immediately.

How should I store Aspercreme?

Store Aspercreme at room temperature and keep it out of reach of children. Close the cap tightly after use.

Packaging Info

Below are the non-prescription pack sizes of Aspercreme with Lidocaine Foot Pain Creme (lidocaine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Aspercreme with Lidocaine Foot Pain Creme.
Details

Drug Information (PDF)

This file contains official product information for Aspercreme with Lidocaine Foot Pain Creme, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of pain.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Adults and children 12 years of age and older should apply a thin layer of the medication to the affected area every 6 to 8 hours, ensuring that it is not applied more than 3 to 4 times daily. The application should be followed by gentle massage until the product is thoroughly absorbed into the skin. It is important to wash hands thoroughly with soap and water after each use to prevent unintentional contact with other areas of the body or with other individuals.

For children under 12 years of age, it is advised to consult a doctor before use.

Contraindications

Use of this product is contraindicated in the following situations:

The product should not be applied in large quantities, as this may lead to adverse effects. It is also contraindicated for use on wounds or on irritated or damaged skin due to the potential for exacerbating the condition. Additionally, the application of this product in conjunction with a heating pad is not recommended, as it may increase the risk of skin irritation or burns.

When utilizing this product, it is important to avoid bandaging the area tightly, as this can restrict circulation. Contact with the eyes and mucous membranes must be avoided to prevent irritation or injury. Furthermore, exposure of the treated area to local heat or direct sunlight should be avoided to minimize the risk of adverse reactions.

Warnings and Precautions

For external use only. This product should not be applied in large quantities, on wounds, or on irritated or damaged skin. Additionally, it is contraindicated for use with a heating pad.

When utilizing this product, it is imperative to adhere strictly to the directions provided. Bandaging should not be done tightly, and contact with the eyes and mucous membranes must be avoided. Furthermore, the treated area should not be exposed to local heat or direct sunlight.

Healthcare professionals should advise patients to discontinue use and seek medical advice if any of the following occur: the condition worsens or symptoms persist beyond 7 days; symptoms resolve and then recur within a few days; there is the presence of redness or excessive skin irritation; or if the patient experiences severe burning pain, swelling, or blistering at the site of application.

It is essential to keep this product out of reach of children. In the event of ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center should be made without delay.

Side Effects

Patients using this product should be aware of several important safety warnings and potential adverse reactions. The product is intended for external use only and should not be applied in large quantities, on wounds, or on irritated or damaged skin. Additionally, it should not be used in conjunction with a heating pad.

While using this product, patients are advised to follow the directions carefully. It is important to avoid bandaging the area tightly and to prevent contact with the eyes and mucous membranes. Patients should also refrain from exposing the treated area to local heat or direct sunlight.

Patients should discontinue use and consult a healthcare professional if any of the following occur: the condition worsens or symptoms persist for more than 7 days; symptoms resolve and then recur within a few days; there is the presence of redness or excessive skin irritation; or if severe burning pain, swelling, or blistering develops at the site of application.

In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Aspercreme with Lidocaine Foot Pain Creme (lidocaine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Aspercreme with Lidocaine Foot Pain Creme.
Details

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents and children aged 12 years and older, the recommended dosage is to apply a thin layer to the affected area every 6 to 8 hours, not exceeding 3 to 4 applications per day.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and lactation. Healthcare providers can offer guidance tailored to individual circumstances, ensuring the safety of both the patient and the developing fetus or nursing infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function provided in the insert. Healthcare professionals should exercise caution when prescribing to patients with renal impairment, as the absence of detailed guidance necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

If pregnant or breast-feeding, it is advised to consult a health professional before use. No non-teratogenic effects have been specified in the available data. Additionally, there are no details provided regarding nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions reported voluntarily or through surveillance programs: severe burning pain, swelling, and blistering at the site of application.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event of swallowing the product, patients should seek medical help or contact a Poison Control Center immediately.

Patients should be instructed not to use the product in large quantities and to avoid applying it on wounds or on irritated or damaged skin. It is important to inform patients that the product should not be used in conjunction with a heating pad.

Healthcare providers should counsel patients to discontinue use and consult a doctor if their condition worsens or if symptoms persist for more than 7 days. Additionally, patients should be advised to stop using the product and seek medical advice if symptoms resolve and then recur within a few days. They should also be informed to stop use and consult a doctor if they experience redness, excessive skin irritation, severe burning pain, swelling, or blistering at the application site.

When using this product, patients should be reminded to follow the directions carefully. They should avoid bandaging the area tightly and refrain from contact with eyes and mucous membranes. Furthermore, patients should be cautioned against exposing the treated area to local heat or direct sunlight.

Storage and Handling

The product is supplied in child-resistant packaging to ensure safety and is designed to be stored at room temperature. It is essential to close the cap tightly after each use to maintain product integrity. Additionally, the product should be kept out of reach of children to prevent accidental ingestion.

Additional Clinical Information

The product is administered topically, with a recommended application of a thin layer to the affected area every 6 to 8 hours for adults and children aged 12 years and older, not exceeding 3 to 4 applications daily.

Clinicians should counsel patients to consult a health professional if they are pregnant or breastfeeding before use. Additionally, it is important to keep the product out of reach of children; if ingested, medical assistance or contact with a Poison Control Center should be sought immediately. No further information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Aspercreme with Lidocaine Foot Pain Creme, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Aspercreme with Lidocaine Foot Pain Creme, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.